Gayatri Bioorganics Intrinsic Value
Gayatri Bioorganics (GAYATRIBI) median intrinsic value is ₹2.34 from 1 valuation models (range ₹2–₹2), vs current price ₹7.80 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit GAYATRIBI share price.
GAYATRIBI Valuation Methods Summary — DCF, Graham Number & P/E
Gayatri Bioorganics intrinsic value across 1 models vs current price ₹7.80 — upside/downside and value range per method. Check Gayatri Bioorganics marketcap in USD to track the company's total market size over time.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹2.34 | ₹2.11 - ₹2.57 | -70.0% | Revenue/Share: ₹0.25, P/S: 0.8x |
GAYATRIBI Intrinsic Value vs Market Price — All Valuation Models
Gayatri Bioorganics fair value range ₹2–₹2 vs current market price ₹7.80 across 1 valuation models. See GAYATRIBI price to book ratio to compare market price against book value per share.
GAYATRIBI Intrinsic Value Analysis — Undervalued or Overvalued?
Gayatri Bioorganics median intrinsic value ₹2.34, current price ₹7.80 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of GAYATRIBI?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Gayatri Bioorganics (GAYATRIBI) is ₹2.34 (median value). With the current market price of ₹7.80, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹2.34 to ₹2.34, indicating ₹2.34 - ₹2.34.
Is GAYATRIBI undervalued or overvalued?
Based on our multi-method analysis, Gayatri Bioorganics (GAYATRIBI) appears to be trading above calculated value by approximately 70.0%.
GAYATRIBI Financial Health — Key Ratios vs Industry Benchmarks
Gayatri Bioorganics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.06 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 2.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 1.00x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
GAYATRIBI Cash Flow Quality — Operating & Free Cash Flow
Gayatri Bioorganics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |